<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Macagno, Annalisa</dc:creator>
  <dc:creator>Bernasconi, Nadia L.</dc:creator>
  <dc:creator>Vanzetta, Fabrizia</dc:creator>
  <dc:creator>Dander, Erica</dc:creator>
  <dc:creator>Sarasini, Antonella</dc:creator>
  <dc:creator>Revello, Maria Grazia</dc:creator>
  <dc:creator>Gerna, Giuseppe</dc:creator>
  <dc:creator>Sallusto, Federica</dc:creator>
  <dc:creator>Lanzavecchia, Antonio</dc:creator>
  <dc:date>2009-12-22</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Human cytomegalovirus (HCMV) is a widely circulating pathogen that causes severe  disease in immunocompromised patients and infected fetuses. By immortalizing  memory B cells from HCMV-immune donors, we isolated a panel of human monoclonal  antibodies that neutralized at extremely low concentrations (90% inhibitory  concentration [IC90] values ranging from 5 to 200 pM) HCMV infection of endothelial,  epithelial, and myeloid cells. With the single exception of an antibody that bound to a  conserved epitope in the UL128 gene product, all other antibodies bound to  conformational epitopes that required expression of two or more proteins of the  gH/gL/UL128-131A complex. Antibodies against gB, gH, or gM/gN were also isolated  and, albeit less potent, were able to neutralize infection of both endothelial-epithelial  cells and fibroblasts. This study describes unusually potent neutralizing antibodies  against HCMV that might be used for passive immunotherapy and identifies, through  the use of such antibodies, novel antigenic targets in HCMV for the design of  immunogens capable of eliciting previously unknown neutralizing antibody responses.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1318965</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/318965</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318965/files/Macagno_JV_2010.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318965</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Journal of Virology. - 2010, vol. 84, no. 2, p. 1005-1013</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
